Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
QleanAir signs US agreements worth USD 1.1 million

QleanAir signs US agreements worth USD 1.1 million

BitgetBitget2026/09/29 15:05
  • QleanAir signed three US cleanroom agreements totaling about USD 1.1 million within a week.
  • Projects cover about 2,700 square feet; deliveries scheduled from end-Q4 2026 through end-Q3 2027.
  • Largest order: USD 545,000 cleanroom for a Southeast state-owned academic health system’s pediatric pharmacy; customer’s 12th room.
  • Houston regenerative medicine customer signed USD 479,000 materials and installation deal; total project value USD 567,000 including prior engineering.
  • Nonprofit academic health system signed USD 78,000 design and engineering contract for a 951-square-foot cleanroom; its fourth project.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. QleanAir AB published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion

Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.

智通财经•2026/11/09 23:57